Clinical trial
Identification and Characterization of Antibacterial Antibodies in Sera of Patients With Cystic Fibrosis
NCT04700358 is registered in ClinicalTrials.gov with University Hospital of Cologne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification and Characterization of Antibacterial Antibodies in Sera of Patients With Cystic Fibrosis
- Lead sponsor
- University Hospital of Cologne
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 1, 2020
- Completion date
- December 31, 2027
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neutralizing antibodies, pulmonary cystic fibrosis